DODGX
Price
$16.85
Change
-$0.11 (-0.65%)
Updated
Jun 2 closing price
Net Assets
120.16B
MCLVX
Price
$31.89
Change
+$0.28 (+0.89%)
Updated
Jun 2 closing price
Net Assets
804.36M
Interact to see
Advertisement

DODGX vs MCLVX

Header iconDODGX vs MCLVX Comparison
Open Charts DODGX vs MCLVXBanner chart's image
DODGX vs MCLVX Comparison Chart in %
View a ticker or compare two or three
VS
DODGX vs. MCLVX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a Buy and MCLVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 120B vs. MCLVX (804M). DODGX pays higher dividends than MCLVX: DODGX (1.24) vs MCLVX (0.43). DODGX was incepted earlier than MCLVX: DODGX (61 years) vs MCLVX (26 years). MCLVX (1.75) is less costly to investors than DODGX (0.51). MCLVX is a more actively managed with annual turnover of: 120.00 vs. DODGX (20.00). MCLVX has a lower initial minimum investment than DODGX: MCLVX (1000) vs DODGX (2500). MCLVX (19.38) and DODGX (18.68) have marching annual gain over last year. DODGX return over 5 years is better than : 155.84 vs. MCLVX (2.80).
DODGXMCLVXDODGX / MCLVX
Total Expense Ratio0.511.5433%
Annual Report Gross Expense Ratio0.511.7529%
Fund Existence61 years26 years-
Gain YTD2.54514.23918%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets120B804M14,925%
Annual Yield % from dividends1.240.43286%
Returns for 1 year18.6819.3896%
Returns for 3 years131.3233.68390%
Returns for 5 years155.842.805,571%
Returns for 10 years466.5763.23738%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVAAX38.42N/A
N/A
JPMorgan Value Advantage A
PCVAX13.00N/A
N/A
Virtus NFJ Small-Cap Value A
RTSAX46.98N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap A
MDOAX12.52N/A
N/A
Morgan Stanley Developing Opportunity A
ERHSX13.49N/A
N/A
Eaton Vance Worldwide Health Sci R